Jerzy–Roch Nofer

6.2k citations

104 papers · 5.0k · 2 hit papers · h-index 36

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Clinical Biochemistry top 1%

Papers in

Molecular Biology 44
- Sphingolipid Metabolism and Signaling 26
- Peroxisome Proliferator-Activated Receptors 8
Surgery 35
- Cholesterol and Lipid Metabolism 25
- Lipoproteins and Cardiovascular Health 7

Co-authors: Gerd Assmann (42 shared papers)Arnold von Eckardstein (13 shared papers)Manfred Fobker (15 shared papers)Bodo Levkau (5 shared papers)Udo Seedorf (19 shared papers)Beate E. Kehrel (7 shared papers)Walter Zidek (14 shared papers)Martin Tepel (15 shared papers)
Journals: Atherosclerosis (8 papers)Arteriosclerosis Thrombosis and Vascular Biology (8 papers)Journal of Biological Chemistry (6 papers)Thrombosis and Haemostasis (4 papers)Biochemical and Biophysical Research Communications (3 papers)
Partner nations: Germany Italy United States

In The Last Decade

Jerzy–Roch Nofer

104 papers receiving 4.9k citations

Jerzy–Roch Nofer's Hit Papers

align trajectories log scale

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 2004 · 510 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Journal of Clinical Investigation
2001 Arteriosclerosis Thrombosis and Vascular Biology

Peers

Countries citing papers authored by Jerzy–Roch Nofer

Since Specialization

Citations

This map shows the geographic impact of Jerzy–Roch Nofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy–Roch Nofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy–Roch Nofer more than expected).

Fields of papers citing papers by Jerzy–Roch Nofer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy–Roch Nofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy–Roch Nofer. The network helps show where Jerzy–Roch Nofer may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerzy–Roch Nofer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerzy–Roch Nofer Line = papers co-authored together Jerzy–Roch Nofer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High Density Lipoproteins and Arteriosclerosis Arteriosclerosis Thrombosis and Vascular Biology ·Arnold von Eckardstein, Jerzy–Roch Nofer, Gerd Assmann Hit paper breakdown →	2001	560
2	HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 Journal of Clinical Investigation ·Jerzy–Roch Nofer, Markus van der Giet, Markus Tölle, Iza Wolinska, Karin von Wnuck Lipinski, Hideo A. Baba, Uwe J.F. Tietge, Axel Gödecke, Isao Ishii, Burkhard Kleuser, Michael Schäfers, Manfred Fobker, Walter Zidek, Gerd Assmann, Jerold Chun, Bodo Levkau Hit paper breakdown →	2004	510
3	HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis ·Jerzy–Roch Nofer, Beate E. Kehrel, Manfred Fobker, Bodo Levkau, Gerd Assmann, Arnold von Eckardstein	2002	473
4	Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids Journal of Biological Chemistry ·Jerzy–Roch Nofer, Bodo Levkau, Iza Wolinska, Ralf Junker, Manfred Fobker, Arnold von Eckardstein, Udo Seedorf, Gerd Assmann	2001	302
5	Atheroprotective Effects of High-Density Lipoproteins Annual Review of Medicine ·Gerd Assmann, Jerzy–Roch Nofer	2003	283
6	FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice Circulation ·Jerzy–Roch Nofer, Martine Bot, Martin F. Brodde, J. Paul Taylor, Paul Salm, Volker Brinkmann, Theo van Berkel, Gerd Assmann, Erik A.L. Biessen	2007	187
7	HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production Arteriosclerosis Thrombosis and Vascular Biology ·Markus Tölle, Alicja Pawlak, Mirjam Schuchardt, Akira Kawamura, Uwe J.F. Tietge, Stefan Lorkowski, Petra Keul, Gerd Assmann, Jerold Chun, Bodo Levkau, Markus van der Giet, Jerzy–Roch Nofer	2008	130
8	HDL₃-Mediated Inhibition of Thrombin-Induced Platelet Aggregation and Fibrinogen Binding Occurs via Decreased Production of Phosphoinositide-Derived Second Messengers 1,2-Diacylglycerol and Inositol 1,4,5-tris-Phosphate Arteriosclerosis Thrombosis and Vascular Biology ·Jerzy–Roch Nofer, Michael Walter, Beate E. Kehrel, Sonja Wierwille, Martin Tepel, Udo Seedorf, Gerd Assmann	1998	111
9	Atheroprotective Effects of High-Density Lipoprotein-Associated Lysosphingolipids Trends in Cardiovascular Medicine ·Jerzy–Roch Nofer, Gerd Assmann	2005	78
10	Low-Density Lipoproteins Inhibit the Na⁺/H⁺Antiport in Human Platelets Circulation ·Jerzy–Roch Nofer, Martin Tepel, Beate E. Kehrel, Sonja Wierwille, Michael Walter, Udo Seedorf, Walter Zidek, Gerd Assmann	1997	77
11	Estrogens and atherosclerosis: insights from animal models and cell systems Journal of Molecular Endocrinology ·Jerzy–Roch Nofer	2012	72
12	Oxidative DNA damage and oxidative stress in subjects occupationally exposed to nitrous oxide (N2O) Mutation research. Fundamental and molecular mechanisms of mutagenesis ·T Wrońska-Nofer, Jerzy–Roch Nofer, Jolanta Jajte, Elżbieta Dziubałtowska, Wiesław Szymczak, Wojciech Krajewski, Wojciech Wąsowicz, K Rydzyński	2011	63
13	Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter Journal of Lipid Research ·Jerzy–Roch Nofer, Alan T. Remaley, Renata Feuerborn, Iza Wolinnéska, Thomas Engel, Arnold von Eckardstein, Gerd Assmann	2006	61
14	Follicular Fluid High Density Lipoprotein-associated Sphingosine 1-Phosphate Is a Novel Mediator of Ovarian Angiogenesis Journal of Biological Chemistry ·Sören von Otte, Jürgen R. J. Paletta, Steffi Becker, Simone König, Manfred Fobker, Robert Greb, Ludwig Kiesel, Gerd Assmann, Klaus Diedrich, Jerzy–Roch Nofer	2005	60
15	Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux Journal of Biological Chemistry ·Jerzy–Roch Nofer, Renata Feuerborn, Bodo Levkau, Andrea Sokoll, Udo Seedorf, Gerd Assmann	2003	60
16	Branched Chain Fatty Acids Induce Nitric Oxide-dependent Apoptosis in Vascular Smooth Muscle Cells Journal of Biological Chemistry ·Susanne Idel, Peter Ellinghaus, Christian Wolfrum, Jerzy–Roch Nofer, Jolein Gloerich, Gerd Assmann, Friedrich Spener, Udo Seedorf	2002	60
17	High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression Atherosclerosis ·Renata Feuerborn, Susen Becker, Francesco Potì, Petra Nagel, Martin F. Brodde, Harmut Schmidt, Christina Christoffersen, Uta Ceglarek, Ralph Burkhardt, Jerzy–Roch Nofer	2016	57
18	Activation of Phosphatidylinositol-Specific Phospholipase C by HDL-Associated Lysosphingolipid. Involvement in Mitogenesis but Not in Cholesterol Efflux Biochemistry ·Jerzy–Roch Nofer, Manfred Fobker, Gunnar Höbbel, Reinhard Voß, Iza Wolinska, Martin Tepel, Walter Zidek, Ralf Junker, Udo Seedorf, Arnold von Eckardstein, Gerd Assmann, Michael Walter	2000	57
19	High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells Biochemical and Biophysical Research Communications ·Jerzy–Roch Nofer, Sven Geigenmüller, Christian Göpfert, Gerd Assmann, Eckhart Buddecke, Annette Schmidt	2003	56
20	Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages Cell and Tissue Research ·Petra May, Hans H. Bock, Jerzy–Roch Nofer	2013	56

About Jerzy–Roch Nofer

Jerzy–Roch Nofer is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Immunology, having authored 104 papers that have together received 5.0k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (26 papers), Cholesterol and Lipid Metabolism (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Platelet Disorders and Treatments (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Lipid metabolism and disorders (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Clinical Biochemistry (343 citations), Surgery (2.0k citations), Cancer Research (628 citations) and Biochemistry (281 citations). Jerzy–Roch Nofer has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Gerd Assmann, Arnold von Eckardstein, Manfred Fobker, Bodo Levkau, Udo Seedorf, Beate E. Kehrel, Walter Zidek, Martin Tepel, Uwe J.F. Tietge and Michael Walter. Their work appears in journals such as Atherosclerosis, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Thrombosis and Haemostasis and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jerzy–Roch Nofer

Impact in

Papers in i

In The Last Decade

Jerzy–Roch Nofer

Jerzy–Roch Nofer's Hit Papers

Peers

Countries citing papers authored by Jerzy–Roch Nofer

Fields of papers citing papers by Jerzy–Roch Nofer

All Works

About Jerzy–Roch Nofer

Explore authors with similar magnitude of impact

Papers in